Concepedia

Publication | Open Access

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

24

Citations

48

References

2022

Year

Abstract

www.ClinicalTrials.gov, identifier: NCT02433067.

References

YearCitations

Page 1